Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Microbot Medical Inc.NASDAQ: MBOT
Other Current Assets · Q1 FY2026 · quarter ended Mar 2026
Other current assets rises 3370.8% from a year ago
Other current assets stood at $1.67M at the end of Q1 FY2026, up 3370.8% from a year earlier and up 311.4% from the prior quarter. Over 3 fiscal years it compounded at +413.0% a year.
Context
- Other current assets amounted to 2.1% of total assets at the end of Q1 FY2026, up 2.0 pp from a year earlier.
- Other current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current assets keeps rising in the next quarterly balance sheet after a +3370.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 405K USD
- Year-over-year change
- +726.5%
- 4-year CAGR
- +46.9%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 405K | +726.5% |
| FY2024 | 2024-12-31 | 49K | +0.0% |
| FY2023 | 2023-12-31 | 49K | +1533.3% |
| FY2022 | 2022-12-31 | 3K | -96.6% |
| FY2021 | 2021-12-31 | 87K | — |
Other Current Assets vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +3370.8% is the highest of 8, against a peer median of -13.8%.
- Other current assets amounts to 2.1% of total assets for MBOT, versus a peer median of 1.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $4.62M USD | — | +27406.7% | 2.0% | |
| Mar 2026 | $3.99M USD | +18.0% | +0.0% | 6.8% | |
| Mar 2026 | $3.25M USD | -31.9% | -16.1% | 1.6% | |
| Mar 2026 | $2.31M USD | +177.6% | +25.4% | 0.9% | |
| Mar 2026 | $1.79M USD | +7.2% | — | 4.2% | |
| Mar 2026 | $1.67M USD | +3370.8% | +413.0% | 2.1% | |
| Mar 2026 | $1.38M USD | -13.8% | +52.9% | 2.7% | |
| Mar 2026 | $244K USD | -89.5% | -63.6% | 1.1% | |
| Mar 2026 | CA$186.2K CAD | -90.1% | -62.6% | 1.2% | |
| Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding MBOT) | — | -13.8% | +0.0% | 1.6% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.